AIGEN INVESTMENT MANAGEMENT, LP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2021$146,000
-58.5%
12,054
-43.2%
0.01%
-80.0%
Q3 2020$352,000
-80.6%
21,211
-73.0%
0.04%
-80.7%
Q2 2020$1,817,000
+2739.1%
78,451
+2075.6%
0.23%
+2812.5%
Q1 2020$64,0003,6060.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
Monaco Asset Management SAM 4,809,601$2,864,5980.85%
Lynx1 Capital Management LP 1,766,815$1,052,3150.70%
CM Management, LLC 800,000$476,4800.51%
Deep Track Capital, LP 18,400,000$10,959,0400.42%
TANG CAPITAL MANAGEMENT LLC 3,939,600$2,346,4260.33%
Acuitas Investments, LLC 721,460$429,7020.25%
RA Capital Management 18,700,000$11,137,7200.22%
GSA CAPITAL PARTNERS LLP 1,841,078$1,0970.09%
UBS OCONNOR LLC 1,376,249$820,2440.02%
Marquette Asset Management, LLC 148,378$88,3740.02%
View complete list of NEKTAR THERAPEUTICS shareholders